User talk:Wikisystole

Notability of Tony Dowe[edit]

A tag has been placed on Tony Dowe, requesting that it be speedily deleted from Wikipedia. This has been done because the article appears to be about a person, group of people, band, club, company, or web content, but it does not indicate how or why the subject is notable: that is, why an article about that subject should be included in an encyclopedia. Under the criteria for speedy deletion, articles that do not assert the subject's importance or significance may be deleted at any time. Please see the guidelines for what is generally accepted as notable.

If you think that you can assert the notability of the subject, you may contest the deletion by adding {{hangon}} to the top of the page (just below the existing speedy deletion or "db" tag), coupled with adding a note on the article's talk page explaining your position, but be aware that once tagged for speedy deletion, if the article meets the criterion it may be deleted without delay. Please do not remove the speedy deletion tag yourself, but don't hesitate to add information to the article that would confirm the subject's notability under Wikipedia guidelines.

For guidelines on specific types of articles, you may want to check out our criteria for biographies, for web sites, for bands, or for companies. Feel free to leave a note on my talk page if you have any questions about this. NeilN 18:40, 29 July 2007 (UTC)[reply]

This article was only 10-20% complete when it was deleted. I was testing the formatting and style and had just begun to add pertinent information. See www.pezshow.com for information relating to this artist, or www.dmbvideos.com. In Boston, MA, this is a locally known and respected musician

WikiProject Pharmacology Collaboration of the Week[edit]

WikiProject Pharmacology is currently organizing a new Collaboration of the Week program, designed to bring drug and medication related articles up to featured status. We're currently soliciting nominations and/or voting on nominations for the first WP:RxCOTW, to begin on September 5, 2007. Please stop by the Pharmacology Collaboration of the Week page to participate! Thanks! Dr. Cash 17:56, 1 September 2007 (UTC)[reply]

Pharmacology Collaboration of the Week[edit]

Aspirin has been selected as this week's Pharmacology Collaboration of the Week! Please help us bring this article up to featured standards during the week. The goal is to nominate this at WP:FAC on September 10, 2007.

Also, please visitWP:RxCOTW to support other articles for the next COTW. Articles that have been nominated thus far include Doxorubicin, Paracetamol (in the lead with 4 support votes so far), Muscle relaxant, Ethanol, and Bufotenin.

In other news:

Bupropion has been promoted to featured status on August 31, 2007.

The Wikipedia:WikiProject Pharmacology main page has been updated and overhauled, to make it easier to find things, as well as to highlight other goals and announcements for the project.

Garrondo is asking for individuals to help review Therapies for multiple sclerosis, as he is considering nominating this article for GA status.

Fvasconcellos notes that discussion is ongoing regarding the current wording of MEDMOS on including dosage information in drug articles. All input is welcome.

Dr. Cash 00:55, 5 September 2007 (UTC)[reply]

WikiProject Pharmacology Update[edit]

Here's a brief update in some of the recent developments of WikiProject Pharmacology!

Aspirin has just completed its two week run as the first Collaboration of the Week! Many thanks to those editors that contributed; the article got a lot of good work accomplished, and in particular, much work was done in fixing up the history section. It's still not quite "done" yet (is a wikipedia article really ever done?), but after two weeks I think it's more important to push onwards with the development of the new collaboration of the week program. I will be fixing up Aspirin in the next few days and possibly nominating it for either GA or FA status.

Muscle relaxant has been selected as the new Collaboration of the week until October 2, 2007! This article is currently rated as a "stub", so it's got quite a bit of work cut out for collaborators! Admittedly, featured status could be a long way off,... but still attainable! At the least, maybe we could at least get it up to meeting the Good article criteria? Please stop by the article and help improve it.

Resveratrol, having recently achieved GA status on August 16, 2007, is now making a run for featured status. This is quite a fascinating compound. If you can, please stop by its discussion page and leave comments in support of it.

Please remember that Wikipedia is not a forum for discussing or dispensing medical advice amongst users. Specifically, talk pages of articles should only be used to discuss improving the actual article in question. To help alleviate this situation, the template {{talkheader}} may be added to the top of talk pages, reminding users of the purpose of such pages. Additionally, unsigned comments and comments by anonymous users that are inappropriate may be removed from talk pages without being considered vandalism.

There was an interesting article on ZDNet last week about Hewlett Packard licensing its patented microneedle technology used in common inkjet printers to be used in transdermal patches to deliver a time-controlled release of drugs to patients. This information could be added to articles such as route of administration or drug delivery.

You are receiving this message because you are listed as one of the participants of WikiProject Pharmacology.

Dr. Cash 04:52, 19 September 2007 (UTC)[reply]

WikiProject Pharmacology Update[edit]

Here are a few updates in the realm of WikiProject Pharmacology:

The Pharmacology Collaboration of the Week has been changed to Collaboration of the Month, based on current participation levels. It is also more likely that articles collaborated on for one month are more likely to achieve featured quality than articles worked on for only a week or two.

The current Collaboration of the Month for November is Receptor antagonist. Please take a look at that article and contribute to it if you get a chance. Ideally, the article should adhere to the featured article criteria.

Therapies for multiple sclerosis is currently a featured article candidate. If you are familiar with the featured article criteria, please visit WP:FAC and review the article.

Anabolic steroid is the wikiproject's newest Featured Article, having been promoted on October 8, 2007.

Theobromine was delisted as a Good Article. The Peer review and GA reassessment discussions provide suggestions on improvement. Muscle relaxant was recently reviewed for Good Article status, but not promoted. Please see the full review full review here for details.

Dr. Cash 22:20, 31 October 2007 (UTC)[reply]

Jock Horror[edit]

This, along with many other cannabis strains, was deleted via AfD due to having no claim to notability along with being unsourced, as an attempt to restrict the number of strains that had their own article to the obviously notable. BLACKKITE 09:54, 22 December 2007 (UTC)[reply]

Image source problem with Image:Nirvana_haze_indoor.jpg[edit]

Image Copyright problem

Thanks for uploading Image:Nirvana_haze_indoor.jpg. I noticed that the file's description page currently doesn't specify who created the content, so the copyright status is unclear. If you did not create this file yourself, you will need to specify the owner of the copyright. If you obtained it from a website, then a link to the website from which it was taken, together with a restatement of that website's terms of use of its content, is usually sufficient information. However, if the copyright holder is different from the website's publisher, their copyright should also be acknowledged.

If you have uploaded other files, consider checking that you have specified their source and tagged them, too. You can find a list of files you have uploaded by following this link. Unsourced and untagged images may be deleted one week after they have been tagged, as described on criteria for speedy deletion. If the image is copyrighted under a non-free license (per Wikipedia:Fair use) then the image will be deleted 48 hours after 02:34, 27 October 2008 (UTC). If you have any questions please ask them at the Media copyright questions page. Thank you. Nv8200p talk 02:34, 27 October 2008 (UTC)[reply]

Image source problem with Image:Nirvana_jock_horror.jpg[edit]

Image Copyright problem

Thanks for uploading Image:Nirvana_jock_horror.jpg. I noticed that the file's description page currently doesn't specify who created the content, so the copyright status is unclear. If you did not create this file yourself, you will need to specify the owner of the copyright. If you obtained it from a website, then a link to the website from which it was taken, together with a restatement of that website's terms of use of its content, is usually sufficient information. However, if the copyright holder is different from the website's publisher, their copyright should also be acknowledged.

If you have uploaded other files, consider checking that you have specified their source and tagged them, too. You can find a list of files you have uploaded by following this link. Unsourced and untagged images may be deleted one week after they have been tagged, as described on criteria for speedy deletion. If the image is copyrighted under a non-free license (per Wikipedia:Fair use) then the image will be deleted 48 hours after 02:34, 27 October 2008 (UTC). If you have any questions please ask them at the Media copyright questions page. Thank you. Nv8200p talk 02:34, 27 October 2008 (UTC)[reply]

Greetings from WikiProject Medicine![edit]

Welcome to WikiProject Medicine!

I noticed you recently added yourself to our Participants' list, and I wanted to welcome you to our project. Our goal is to facilitate collaboration on medicine-related articles, and everyone is welcome to join (regardless of medical qualifications!). Here are some suggested activities:

Read our Manual of Style for medical articles and guide to Reliable medical sources
Join in editing our collaboration of the week (the current one is Chronic obstructive pulmonary disease)
Discuss with other members in the doctor's mess
Have a look at some related WikiProjects
Have a look at the collaboration dashboard

If you have any questions, don't hesitate to ask at the project talk page, or feel free to ask me on my talk page.

Again, welcome! JFW | T@lk 21:20, 16 December 2008 (UTC)[reply]

Cardiology task force[edit]

Cardiology task force is looking for editors to help build and maintain comprehensive, informative, balanced articles related to Cardiology on Wikipedia. Start by adding your name to the list of participants at Cardiology task force Participants. ECG Unit (Welcome!)

-- Addbot (talk) 00:11, 7 January 2013 (UTC)[reply]

T.F.AlHammouri (talk) 12:33, 2 March 2009 (UTC)[reply]

The Wikipedia Library now offering accounts from Cochrane Collaboration (sign up!)[edit]

Cochrane Collaboration is an independent medical nonprofit organization consisting of over 28,000 volunteers in more than 100 countries. The collaboration was formed to organize medical scholarship in a systematic way in the interests of evidence-based research: the group conducts systematic reviews of randomized controlled trials of health-care interventions, which it then publishes in the Cochrane Library.

Cochrane has generously agreed to give free, full-access accounts to 100 medical editors. Individual access would otherwise cost between $300 and $800 per account. Thank you Cochrane!

If you are stil active as a medical editor, come and sign up :)

Cheers, Ocaasi^{t | c} 20:01, 16 June 2013 (UTC)[reply]

The Wikipedia Library now offering accounts from Cochrane Collaboration (sign up!)[edit]

The Wikipedia Library gets Wikipedia editors free access to reliable sources that are behind paywalls. Because you are signed on as a medical editor, I thought you'd want to know about our most recent donation from Cochrane Collaboration.

Cochrane Collaboration is an independent medical nonprofit organization that conducts systematic reviews of randomized controlled trials of health-care interventions, which it then publishes in the Cochrane Library.
Cochrane has generously agreed to give free, full-access accounts to 100 medical editors. Individual access would otherwise cost between $300 and $800 per account.
If you are still active as a medical editor, come and sign up :)

Cheers, Ocaasi^{t | c} 20:16, 16 June 2013 (UTC)[reply]